EDAP (EDAP) Showcases Focal One's Growing Impact at AUA Annual Meeting | EDAP Stock News

Author's Avatar
3 days ago
Article's Main Image

EDAP TMS (EDAP, Financial) is set to make a significant impact at the 120th American Urological Association Annual Meeting, with Focal One having its most substantial presence yet. The event marks an important milestone for the company, as it showcases the increasing adoption of its Focal One Robotic High-Intensity Focused Ultrasound (HIFU) platform among urology professionals worldwide.

The company will present numerous hands-on simulations and live demonstrations during the conference, offering a comprehensive exposure to their innovative technology. Top experts in focal therapy will conduct these sessions, providing attendees with in-depth insights into the platform's capabilities and applications.

Prior to the main event, EDAP TMS will host the inaugural Focal One Robotic HIFU Masterclass at the Keck School of Medicine, USC in Los Angeles. This masterclass will feature several live Focal One procedures and provide additional opportunities for interactive learning through simulations, led by leading authorities in the field.

Wall Street Analysts Forecast

1914645670111899648.png

Based on the one-year price targets offered by 2 analysts, the average target price for Edap TMS SA (EDAP, Financial) is $3.28 with a high estimate of $4.55 and a low estimate of $2.02. The average target implies an upside of 128.07% from the current price of $1.44. More detailed estimate data can be found on the Edap TMS SA (EDAP) Forecast page.

Based on the consensus recommendation from 3 brokerage firms, Edap TMS SA's (EDAP, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Edap TMS SA (EDAP, Financial) in one year is $7.97, suggesting a upside of 453.47% from the current price of $1.44. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Edap TMS SA (EDAP) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.